#	Pagina
attuale pagina	/open-h2020/projects/211148/index.html

Opendata, web and dolomites

ACUSLABS

A new tool in drug development: mapping of compound-protein interaction using forward genetics

Total Cost €

EC-Contrib. €

Partnership

Views

ACUSLABS project word cloud

Explore the words cloud of the ACUSLABS project. It provides you a very rough idea of what is the project "ACUSLABS" about.

small ground resolution interaction action start initial unmatched development unprecedented company chemotherapeutic interactions optimal biological medicines poc mechanism bioactive desired erc solution strategies undesired structures service breaking molecules drugs found customers

Project "ACUSLABS" data sheet

The following table provides information about the project.

Coordinator	MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV Organization address address: HOFGARTENSTRASSE 8 city: MUENCHEN postcode: 80539 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Germany [DE]
Total cost	149˙563 €
EC max contribution	149˙563 € (100%)
Programme	1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
Code Call	ERC-2017-PoC
Funding Scheme	ERC-POC
Starting year	2017
Duration (year-month-day)	from 2017-07-01 to 2018-12-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV Organization address address: HOFGARTENSTRASSE 8 city: MUENCHEN postcode: 80539 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (MUENCHEN)	coordinator	149˙563.00

Map

Project objective

Development of new medicines such as chemotherapeutic drugs requires a detailed understanding of their biological mechanism of action. What are the desired and undesired interactions with biological molecules? It is our goal to found a start-up company that will provide a solution to this challenge. Using novel and ground-breaking approaches we can identify target structures and interaction partners of small bioactive molecules at an unmatched and unprecedented resolution. ERC PoC funding will be essential to support our activities to identify optimal strategies and initial customers for our service.

Publications

List of publications.
year	authors and title	journal	last update
2018	Moritz Horn, Virginia Kroef, Kira Allmeroth, Nicole Schuller, Stephan Miethe, Martin Peifer, Josef M. Penninger, Ulrich Elling, Martin S. Denzel Unbiased compound-protein interface mapping and prediction of chemoresistance loci through forward genetics in haploid stem cells published pages: , ISSN: 1949-2553, DOI: 10.18632/oncotarget.24305	Oncotarget 9/11	2019-05-28

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ACUSLABS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ACUSLABS" are provided by the European Opendata Portal: CORDIS opendata.